Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC

Por Pott, Leona L, Hagemann, Sascha, Reis, Henning, Lorenz, Kristina, Bracht, Thilo, Herold, Thomas, Skryabin, Boris V, Megger, Dominik A, Kälsch, Julia, Weber, Frank, Sitek, Barbara, Baba, Hideo A
Publicado no Oncotarget (2017)